Henan Genuine Biotech Co., Ltd.
Clinical trials sponsored by Henan Genuine Biotech Co., Ltd., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New HIV pill CL-197 shows promise in early trial for untreated patients Results expected Dec 2026 (estimated)
- New drug combo targets tough lung cancer in early trial Results expected Jul 2027 (estimated)
-
Healthy volunteers test new HIV and COVID-19 drug in safety study
Knowledge-focused CompletedThis study tested how the drug azvudine moves through the body and whether it is safe in 24 healthy adults (ages 18-45) and healthy elderly people (ages 60-85). Participants took a single dose of 5 mg, then after a break took the same dose daily for 7 days. The goal was to measur…
Phase 1 • Sponsor: Henan Genuine Biotech Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
HIV drug combo tested in 15 healthy volunteers
Knowledge-focused CompletedThis completed Phase 1 trial tested how the HIV drug azvudine (FNC) interacts with another HIV drug, Aluvia (lopinavir/ritonavir), in 15 healthy adults. Participants took the drugs alone and together over three 5-day cycles. The goal was to measure drug levels in the blood and ch…
Phase 1 • Sponsor: Henan Genuine Biotech Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC